Skip to content
Clinical Trials – home

MUDr. Jan Kvasnicka CSc

Verified siteinfo

Czechia Turkmenska 1417/8, 101 00 Prague, Czechia

  • Hypertriglyceridaemia · Atrial fibrillation
  • Adult patients

About Specializations

MUDr. Jan Kvasnicka CSc in Prague, Czechia specialises in clinical trials of conditions such as Hypertriglyceridaemia, Atrial fibrillation, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases at MUDr. Jan Kvasnicka CSc

This research site in Prague is conducting clinical trials focused on cardiovascular disease, with a strong emphasis on atrial fibrillation and heart failure. The studies are designed to assess new treatment options and compare how well they help manage serious heart conditions.

  • Evaluating a new approach to reduce bleeding risk in people with atrial fibrillation
  • Testing combination treatment strategies for heart failure with reduced heart pumping function

The work at this health care institution aims to improve both safety and effectiveness of care for patients living with complex heart conditions.

Nutritional and Metabolic Diseases

Clinical research here also covers nutritional and metabolic diseases, especially hypertriglyceridemia and severe hypertriglyceridemia. These trials are focused on lowering elevated triglyceride levels and helping better control lipid-related health risks.

  • Assessing a therapy intended to reduce fasting serum triglycerides in hypertriglyceridemia
  • Studying treatment options for severe hypertriglyceridemia to improve metabolic health

This area of research is centered on finding more effective ways to manage abnormal blood fat levels and support long-term cardiovascular risk reduction.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Turkmenska 1417/8101 00 PragueCzechia
Recruiting now
no trials
Conditions studied
2
Partner status
Verified site

More sites in PragueCzechia

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Hypertriglyceridaemia

Not recruiting

Study to Evaluate Plozasiran for Adults with High Triglycerides

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Hypertriglyceridaemia

Not recruiting

Study on Plozasiran and ARO-APOC3 for Adults with Severe Hypertriglyceridemia

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Atrial fibrillation

Not recruiting

Study on the Safety and Tolerability of Abelacimab Compared to Rivaroxaban in Patients with Atrial Fibrillation

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.